Cytomegalovirus Positive Brain Neoplasms

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2023-06-18
Clinical Trial Update: Autologous CMV-Specific Cytotoxic T Cells and Temozolomide in Treating Patients With Glioblastoma [Phase 1, Phase 2]
Phase 1/2 trial evaluating autologous CMV-specific cytotoxic T cells with temozolomide in glioblastoma has completed with posted results.